Literature DB >> 29119196

[Optical coherence tomography in neuromyelitis optica spectrum disorders].

F C Oertel1, H Zimmermann1, A U Brandt1, F Paul2,3,4.   

Abstract

Neuromyelitis optica spectrum disorders (NMOSD) are mostly relapsing inflammatory conditions of the central nervous system (CNS). In 55% of the cases of NMOSD optic neuritis (ON) is the most frequent first manifestation and can cause severe damage to the afferent visual system and the retina with resultant severe visual impairment. In recent years, investigations of the retina as part of the CNS by optical coherence tomography (OCT) has been shown to be a valid and efficient method for diagnostics and evaluation of the disease course in NMOSD. In addition, OCT not only shows severe damage of the afferent visual system due to multiple bouts of ON but also reveals NMOSD-specific intraretinal pathologies. The latter could be just as important for future differential diagnostics as for the evaluation of potential therapeutic targets. This article briefly reviews the principles of the OCT technique and describes its relevance for the diagnostics and assessment of disease course in NMOSD.

Entities:  

Keywords:  Imaging; Intraretinal pathologies; Optic nerve inflammation; Optic neuritis; Retinal nerve fiber layer

Mesh:

Year:  2017        PMID: 29119196     DOI: 10.1007/s00115-017-0444-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  124 in total

1.  A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.

Authors:  Olivier Outteryck; Bilal Majed; Sabine Defoort-Dhellemmes; Patrick Vermersch; Hélène Zéphir
Journal:  Mult Scler       Date:  2015-03-31       Impact factor: 6.312

2.  MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.

Authors:  Sven Jarius; Klemens Ruprecht; Ingo Kleiter; Nadja Borisow; Nasrin Asgari; Kalliopi Pitarokoili; Florence Pache; Oliver Stich; Lena-Alexandra Beume; Martin W Hümmert; Marius Ringelstein; Corinna Trebst; Alexander Winkelmann; Alexander Schwarz; Mathias Buttmann; Hanna Zimmermann; Joseph Kuchling; Diego Franciotta; Marco Capobianco; Eberhard Siebert; Carsten Lukas; Mirjam Korporal-Kuhnke; Jürgen Haas; Kai Fechner; Alexander U Brandt; Kathrin Schanda; Orhan Aktas; Friedemann Paul; Markus Reindl; Brigitte Wildemann
Journal:  J Neuroinflammation       Date:  2016-09-27       Impact factor: 8.322

3.  Brain parenchymal damage in neuromyelitis optica spectrum disorder - A multimodal MRI study.

Authors:  F Pache; H Zimmermann; C Finke; A Lacheta; S Papazoglou; J Kuchling; J Wuerfel; B Hamm; K Ruprecht; F Paul; A U Brandt; M Scheel
Journal:  Eur Radiol       Date:  2016-03-24       Impact factor: 5.315

Review 4.  [Neuromyelitis optica].

Authors:  B Wildemann; S Jarius; F Paul
Journal:  Nervenarzt       Date:  2013-04       Impact factor: 1.214

5.  Ultrahigh-Field MR (7 T) Imaging of Brain Lesions in Neuromyelitis Optica.

Authors:  Ilya Kister; Joseph Herbert; Yongxia Zhou; Yulin Ge
Journal:  Mult Scler Int       Date:  2013-01-27

6.  Imaging the visual pathway in neuromyelitis optica.

Authors:  Caspar F Pfueller; Friedemann Paul
Journal:  Mult Scler Int       Date:  2011-03-16

7.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders.

Authors:  Dean M Wingerchuk; Brenda Banwell; Jeffrey L Bennett; Philippe Cabre; William Carroll; Tanuja Chitnis; Jérôme de Seze; Kazuo Fujihara; Benjamin Greenberg; Anu Jacob; Sven Jarius; Marco Lana-Peixoto; Michael Levy; Jack H Simon; Silvia Tenembaum; Anthony L Traboulsee; Patrick Waters; Kay E Wellik; Brian G Weinshenker
Journal:  Neurology       Date:  2015-06-19       Impact factor: 9.910

8.  Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Authors:  Nasrin Asgari; Eoin P Flanagan; Kazuo Fujihara; Ho Jin Kim; Hanne P Skejoe; Jens Wuerfel; Hiroshi Kuroda; Su Hyun Kim; Elisabeth Maillart; Romain Marignier; Sean J Pittock; Friedemann Paul; Brian G Weinshenker
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-04-21

9.  Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.

Authors:  Rhian Raftopoulos; Simon J Hickman; Ahmed Toosy; Basil Sharrack; Shahrukh Mallik; David Paling; Daniel R Altmann; Marios C Yiannakas; Prasad Malladi; Rose Sheridan; Ptolemaios G Sarrigiannis; Nigel Hoggard; Martin Koltzenburg; Claudia A M Gandini Wheeler-Kingshott; Klaus Schmierer; Gavin Giovannoni; David H Miller; Raju Kapoor
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

10.  Foveal thinning in neuromyelitis optica: A sign of retinal astrocytopathy?

Authors:  Takashi Yamamura; Ichiro Nakashima
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-04-11
View more
  3 in total

Review 1.  Optical coherence tomography in neuromyelitis optica spectrum disorders: potential advantages for individualized monitoring of progression and therapy.

Authors:  Frederike C Oertel; Hanna Zimmermann; Friedemann Paul; Alexander U Brandt
Journal:  EPMA J       Date:  2017-12-22       Impact factor: 6.543

Review 2.  Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis.

Authors:  Nadja Borisow; Masahiro Mori; Satoshi Kuwabara; Michael Scheel; Friedemann Paul
Journal:  Front Neurol       Date:  2018-10-23       Impact factor: 4.003

3.  Magnetic Resonance Image in Monitor and Diagnosis of Patients with Neuromyelitis Optica.

Authors:  Shujuan Lu; Dongming Wang; Fengxian Zhang; Meilan Liu
Journal:  Contrast Media Mol Imaging       Date:  2022-03-17       Impact factor: 3.161

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.